Universal- Beteiligungs- und Servicegesellschaft mbH
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 2057170
FRANKFURT AM MAIN, 2M
Position in SUPN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$5,354,463
+$1,610,557 QoQ
Shares Held
115,125
+58.9% QoQ
Ownership
0.198%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#59
of 335 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Universal- Beteiligungs- und Servicegesellschaft mbH holds $148,218,095 across 23 Drug Manufacturers - Specialty & Generic names. SUPN ranks #10 (3.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
775,868 | $55,753,874 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
99,912 | $16,839,168 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
18,152 | $9,835,298 | |
| 4 | ELAN |
Elanco Animal Health Inc
|
391,678 | $9,639,195 | |
| 5 | VTRS |
Viatris Inc
|
569,358 | $9,041,405 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
172,124 | $7,062,247 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
99,852 | $6,385,535 | |
| 8 | ALKS |
Alkermes plc.
|
119,004 | $6,235,809 |
All Filings in SUPN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,354,463 | 115,125 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $3,743,906 | 72,430 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,998,166 | 80,446 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $5,249,062 | 109,836 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $2,696,031 | 85,534 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $2,147,908 | 65,585 | Shares | Defined | 2025-05-06 | |
| No filing history on record for this holder in this stock. | ||||||